These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31045296)

  • 1. Outcomes of Micra leadless pacemaker implantation with uninterrupted anticoagulation.
    Kiani S; Black GB; Rao B; Thakkar N; Massad C; Patel AV; Merchant FM; Hoskins MH; De Lurgio DB; Patel AM; Shah AD; Leon AR; Westerman SB; Lloyd MS; El-Chami MF
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1313-1318. PubMed ID: 31045296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural anticoagulation therapy in patients undergoing micra leadless pacemaker implantation.
    Kadado AJ; Chalhoub F
    Int J Cardiol; 2023 Jan; 371():221-225. PubMed ID: 36115436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
    Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker.
    El-Chami MF; Clementy N; Garweg C; Omar R; Duray GZ; Gornick CC; Leyva F; Sagi V; Piccini JP; Soejima K; Stromberg K; Roberts PR
    JACC Clin Electrophysiol; 2019 Feb; 5(2):162-170. PubMed ID: 30784685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker.
    Garg A; Koneru JN; Fagan DH; Stromberg K; Padala SK; El-Chami MF; Roberts PR; Piccini JP; Cheng A; Ellenbogen KA
    Heart Rhythm; 2020 Dec; 17(12):2056-2063. PubMed ID: 32763431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leadless pacemaker implant in patients with pre-existing infections: Results from the Micra postapproval registry.
    El-Chami MF; Johansen JB; Zaidi A; Faerestrand S; Reynolds D; Garcia-Seara J; Mansourati J; Pasquie JL; McElderry HT; Roberts PR; Soejima K; Stromberg K; Piccini JP
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):569-574. PubMed ID: 30661279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leadless pacing with Micra TPS: A comparison between right ventricular outflow tract, mid-septal, and apical implant sites.
    Garweg C; Vandenberk B; Foulon S; Haemers P; Ector J; Willems R
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2002-2011. PubMed ID: 31338871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rationale and design of the Micra Transcatheter Pacing Study: safety and efficacy of a novel miniaturized pacemaker.
    Ritter P; Duray GZ; Zhang S; Narasimhan C; Soejima K; Omar R; Laager V; Stromberg K; Williams E; Reynolds D;
    Europace; 2015 May; 17(5):807-13. PubMed ID: 25855677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and long-term effectiveness of a non-apical Micra pacemaker implantation in a referral centre for lead extraction.
    Bongiorni MG; Della Tommasina V; Barletta V; Di Cori A; Rogani S; Viani S; Segreti L; Paperini L; Soldati E; De Lucia R; Zucchelli G
    Europace; 2019 Jan; 21(1):114-120. PubMed ID: 29893837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment--the FinPAC study.
    Airaksinen KE; Korkeila P; Lund J; Ylitalo A; Karjalainen P; Virtanen V; Raatikainen P; Koivisto UM; Koistinen J
    Int J Cardiol; 2013 Oct; 168(4):3679-82. PubMed ID: 23849104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
    Cano O; Muñoz B; Tejada D; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
    Heart Rhythm; 2012 Mar; 9(3):361-7. PubMed ID: 22001709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study.
    Duray GZ; Ritter P; El-Chami M; Narasimhan C; Omar R; Tolosana JM; Zhang S; Soejima K; Steinwender C; Rapallini L; Cicic A; Fagan DH; Liu S; Reynolds D;
    Heart Rhythm; 2017 May; 14(5):702-709. PubMed ID: 28192207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Safety and Feasibility of Same-Day Discharge After Implantation of MICRA Transcatheter Leadless Pacemaker System.
    Kiani S; Black GB; Rao B; Thakkar N; Massad C; Patel AV; Lu MLR; Merchant FM; Hoskins MH; De Lurgio DB; Patel AM; Shah AD; Leon AR; Westerman SB; Lloyd MS; El-Chami MF
    J Atr Fibrillation; 2019 Jun; 12(1):2153. PubMed ID: 31687066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of anticoagulation in patients undergoing leadless pacemaker implantation.
    San Antonio R; Chipa-Ccasani F; Apolo J; Linhart M; Trotta O; Pujol-López M; Niebla M; Alarcón F; Trucco E; Arbelo E; Roca-Luque I; Guasch E; Brugada J; Mont L; Tolosana JM
    Heart Rhythm; 2019 Dec; 16(12):1849-1854. PubMed ID: 31125672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leadless pacing using the transcatheter pacing system (Micra TPS) in the real world: initial Swiss experience from the Romandie region.
    Valiton V; Graf D; Pruvot E; Carroz P; Fromer M; Bisch L; Tran VN; Cook S; Scharf C; Burri H
    Europace; 2019 Feb; 21(2):275-280. PubMed ID: 30202950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry.
    El-Chami MF; Garweg C; Iacopino S; Al-Samadi F; Martinez-Sande JL; Tondo C; Johansen JB; Prat XV; Piccini JP; Cha YM; Grubman E; Bordachar P; Roberts PR; Soejima K; Stromberg K; Fagan DH; Clementy N
    Heart Rhythm; 2022 Feb; 19(2):228-234. PubMed ID: 34757189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience with transcatheter pacemaker implantation for adults with congenital heart disease.
    Russell MR; Galloti R; Moore JP
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1362-1366. PubMed ID: 31045294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System).
    Tjong FVY; Knops RE; Neuzil P; Petru J; Sediva L; Wilde AAM; Sperzel J; Reddy VY
    Circulation; 2018 Feb; 137(6):633-635. PubMed ID: 29431664
    [No Abstract]   [Full Text] [Related]  

  • 19. Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker.
    Hauser RG; Gornick CC; Abdelhadi RH; Tang CY; Casey SA; Sengupta JD
    Heart Rhythm; 2021 Jul; 18(7):1132-1139. PubMed ID: 33713856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantation of the Micra transcatheter pacing system: Single Polish center experience with the real costs of hospitalization analysis.
    Grabowski M; Michalak M; Gawałko M; Gajda S; Cacko A; Januszkiewicz Ł; Kołodzińska A; Mitkowski PP; Duray GZ; Opolski G
    Cardiol J; 2020; 27(1):47-53. PubMed ID: 30155871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.